F. Tzortzatoustathopoulou et al., EFFECT OF TRIMETHOPRIM-SULFAMETHOXAZOLE IN LANGERHANS CELL HISTIOCYTOSIS - PRELIMINARY-OBSERVATIONS, Medical and pediatric oncology, 25(2), 1995, pp. 74-78
Twenty-three children with Langerhans' cell histiocytosis (LCH) have b
een treated with trimethoprim-sulphamethoxazole CT-S) in a 4-year peri
od. The child ren are classified in two main groups according to the e
xtent of their disease. Group A includes 16 children with single syste
m disease and group B, seven children with multisystem disease. All pa
tients were treated for 4 weeks to 3 months. The results of treatment
are evaluated in terms of response in individual organs involved. All
children with single system disease had a good response to the drug. C
hildren with multisystem disease had a good response to some organs bu
t a poorer outcome for the lungs and for the blood. These patients did
not respond even to conventional chemotherapy. (C) 1995 Wiley-Liss, I
nc.